Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Lantheus Holdings Inc LNTH

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company. The Company is engaged in delivering science to enable clinicians to find, fight and follow disease to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic... see more

Recent & Breaking News (NDAQ:LNTH)

Lantheus to Acquire Progenics to Form a Leading Precision Diagnostics Imaging and Therapeutics Company

Business Wire October 2, 2019

Lantheus Holdings to Present at the Wells Fargo Securities 2019 Healthcare Conference

Business Wire August 22, 2019

Lantheus Holdings, Inc. Reports Second Quarter 2019 Financial Results

Business Wire July 25, 2019

Lantheus Holdings to Host Second Quarter 2019 Earnings Conference Call on July 25, 2019 at 8:00 a.m. Eastern Time

Business Wire July 11, 2019

Lantheus Announces Presentation of New Patient Outcomes Data for DEFINITY® at the American Society of Echocardiography 2019 Annual Scientific Sessions

Business Wire June 24, 2019

Lantheus Announces New Patient Outcomes Data for DEFINITY® to be Presented at the American Society of Echocardiography 2019 Annual Scientific Sessions

Business Wire June 20, 2019

Lantheus Announces Strategic Collaboration with NanoMab to Provide a Novel Biomarker for Clinical Development and Management of Immuno-Oncology Therapies

Business Wire May 30, 2019

Lantheus Holdings, Inc. to Present at the Jefferies 2019 Global Healthcare Conference

Business Wire May 22, 2019

Lantheus Holdings, Inc. to Present at the 2019 UBS Global Healthcare Conference

Business Wire May 7, 2019

Lantheus Holdings, Inc. Reports First Quarter 2019 Financial Results

Business Wire April 30, 2019

Lantheus Holdings to Host First Quarter 2019 Earnings Conference Call on April 30, 2019 at 8:00 a.m. Eastern Time

Business Wire April 16, 2019

Lantheus Enters Strategic Collaboration with Cerevast for Potential New Eye Care Application Using Microbubbles

Business Wire April 2, 2019

Lantheus Announces Upcoming Retirement of Chief Medical Officer in September 2019 and Promotion of Senior Vice President, Technical Operations to Chief Operations Officer

Business Wire March 25, 2019

Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results

Business Wire February 19, 2019

Lantheus Holdings Announces Earnings Release and Conference Call Dates for the Fourth Quarter and Full Year 2018

Business Wire February 5, 2019

Lantheus Holdings to Present at the BMO Prescriptions for Success Healthcare Conference

Business Wire November 28, 2018

Report: Developing Opportunities within Pitney Bowes, Alteryx, Summit Materials, MasTec, Lantheus, and Hudson Pacific Properties — Future Expectations, Projections Moving into 2018

GlobeNewswire November 12, 2018

Lantheus Holdings to Present at Upcoming Investor Conferences

Business Wire November 1, 2018

Lantheus Holdings, Inc. Reports Third Quarter 2018 Financial Results

Business Wire October 30, 2018

Lantheus Holdings to Host Third Quarter 2018 Earnings Conference Call on October 30, 2018 at 4:30 p.m. Eastern Time

Business Wire October 16, 2018